drugset

drugset / Trial / NCT01639560

Varenicline for Light Smokers

NCT01639560 ↗

Phase 4 Completed 93 enrolled Mayo Clinic Pfizer · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if varenicline is effective in treating tobacco dependence in adults who smoke 5-10 cigarettes per day.

Timeline

Start: 2013-01
Primary completion: 2015-12
Completion: 2016-06

Publications

Results Ebbert JO, Croghan IT, Hurt RT, Schroeder DR, Hays JT. Varenicline for Smoking Cessation in Light Smokers. Nicotine Tob Res. 2016 Oct;18(10):2031-5. doi: 10.1093/ntr/ntw123. Epub 2016 Apr 26.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Varenicline	Small molecule	1 mg	—

Indications

No indication recorded.